← Y Combinator MODERATE General
Programme Research
Y Combinator ·
Programme Site
MEDIUM confidence Researched 2026-08-04 20:35 · profile: researcher
Y Combinator funds early-stage startups with a strong founder-market fit, providing $500,000 in standard deals to help them build products people want. It exists to accelerate the growth of ambitious, technical founders who can rapidly iterate and scale a venture, with a particular focus on AI and biotech innovations.
- Founder quality: technical ability, resilience, and clarity of vision. - Market potential: large, growing, or underserved market with a clear problem. - Product/idea: novel, defensible, and with a clear path to a minimum viable product. - Traction: early users, revenue, or proof-of-concept (e.g., 500+ employees at top pharma in 3 weeks). - Scalability: potential for rapid growth and venture-scale returns. - Fit with YC's network: ability to benefit from YC's mentorship and alumni community.
YC funds a diverse range of startups, but typical winners are technical founders (often engineers or scientists) with a working prototype or early traction. Examples from the page include Enjamb Labs, a biotech AI startup with 2 employees and early enterprise adoption, and other YC companies like Stripe, Airbnb, and DoorDash, which started with strong founder-market fit and rapid iteration.
The ideal applicant is a technical founder (or small team) with deep domain expertise, a clear, scalable product idea, and early evidence of traction or a compelling proof-of-concept. They are coachable, move fast, and are building in a large market where AI or software can create a significant advantage.
For Eniola, the strongest angle is to pitch TOPOLOGIX as a venture, not a research project. Frame it as a software platform that predicts drug-resistance mutations from sequence data, addressing a critical bottleneck in drug development. Highlight the proof-of-concept (AUROC 0.804 on Platinum benchmark, beating structure-based tools) and the potential to scale into a SaaS product for pharma, leveraging Eniola's software engineering and ML skills to build a deployable tool.
YC typically funds full-time founders, and Eniola is currently enrolled in an M.Sc. program and employed as a National Product Manager. This may raise concerns about commitment and ability to dedicate 100% effort to the startup. Also, the venture is at an early stage with no clear revenue or user traction, which is a competitive disadvantage compared to startups like Enjamb Labs.
2026-08-04 19:57 · medium confidence
2026-07-30 08:50 · medium confidence